Biotechnology

Filter

Current filters:

None

Popular Filters

1930 to 1954 of 2375 results

Biogen Idec and Isis Pharma ink deal on targeting myotonic dystrophy

02-07-2012

In a second accord between the US biotech companies this year, Biogen Idec (Nasdaq: BIBB) and Isis Pharmaceuticals…

Biogen IdecBiotechnologyIsis PharmaceuticalsLicensingRare diseasesResearch

GlaxoSmithKline $2.6 billion tender offer for Human Genome Sciences saga continues

02-07-2012

Continuing its attempts to gain control of its development partner Human Genome Sciences (Nasdaq: HGSI),…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Progress on common EU patent with agreement on site of Unified Patent Court

02-07-2012

The European Council has finally reached agreement on the location of a Unified Patent Court (UPC) for…

BiotechnologyEuropePatentsPharmaceutical

Selvita and Orion achieve research milestone in Alzheimer's disease program

01-07-2012

Polish biotech firm Selvita (PL:SLV) says that its collaboration with Finland-based Orion Corp (Nasdaq…

BiotechnologyNeurologicalOrion PharmaPharmaceuticalResearchSelvita

Gilead files elvitegravir and cobicistat with FDA; AHF plea on Quad pricing

29-06-2012

US biotech firm Gilead Sciences (Nasdaq: GILD), world's largest maker of HIV drugs, has submitted a New…

Anti-viralsBiotechnologycobicistatelvitegravirGilead SciencesNorth AmericaPricingQuadRegulation

Theradiag acquires Prestizia and its MicroRNA technology platform

28-06-2012

Theradiag, (previously Biomedical Diagnostics), a Paris, France-based theranostics and in vitro diagnostics…

BiotechnologyMergers & AcquisitionsPrestiziaTheradiag

Collaboration, not competition, could spur innovation, but barriers remain

28-06-2012

Arising from the murmurings and chatter emanating from the 2012 BIO International Convention was a common…

BiotechnologyFinancialLicensingPharmaceuticalResearch

Latin America progress and challenges in expanding access to HIV treatment highlighted by PAHO

28-06-2012

A number of countries in Latin America and the Caribbean - including Argentina, Brazil, Chile, Cuba,…

Anti-viralsBiotechnologyHealthcarePharmaceuticalSouth America

Australia's Greens want end to Big Pharma inducements

28-06-2012

Ahead of an announcement by pharma trade group Medicines Australia on a new Code of Conduct this week,…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

UK Phase I clinical trials insurance guidance published

27-06-2012

Three UK trade groups, the Association of the British Pharmaceutical Industry (ABPI), the BioIndustry…

BiotechnologyEuropeFinancialPharmaceuticalResearch

After recent R&D disappointments, pharma pipelines improving, says Thomson Reuters

27-06-2012

The pharmaceutical industry's research productivity is finally improving after years of disappointment,…

BiotechnologyMarkets & MarketingPharmaceuticalResearch

Australian patients to benefit from new PBS listings; OTC reforms

26-06-2012

The listing of 11 prescription medicines on the Australian Pharmaceutical Benefits Scheme (PBS) has been…

Asia-PacificBiotechnologyHealthcarePharmaceuticalPricingRegulation

Compugen and Merck Serono set up biomarker company Neviah Genomics

25-06-2012

German drug major Merck KGaA's (MRK: DE) Merck Serono division and Israel-based Compugen (Nasdaq: CGEN)…

BiotechnologyCompugenMerck KGaAMerck SeronoMergers & AcquisitionsResearch

Specialist funds launched to support novel regenerative therapies in UK

25-06-2012

Exclusive funding for regenerative medicine projects with academic and industry collaborators were launched…

BiotechnologyEuropeFinancialPharmaceuticalResearch

Sales of patented drug products in Canada flat due to lack of new high-volume blockbusters

25-06-2012

In 2011, sales of patented drug products in Canada increased toC$13.1 billion ($12.8 billion) from C$12.9…

BiotechnologyMarkets & MarketingNorth AmericaPharmaceuticalPricingResearch

Celgene slumps as it pulls new EU indication filing for Revlimid

22-06-2012

Celgene International, the European subsidiary of USA-based Celgene Corp (Nasdaq: CELG), has provided…

BiotechnologyCelgeneEuropeFinancialOncologyPharmaceuticalpomalidomideRegulationRevlimid

CSL Biotherapies indentifies likely reason for Fluvax problems

21-06-2012

Australia's largest biotech firm CSL Biotherapies, a division of CSL Limited (ASX: CSL) today presented…

Asia-PacificBiotechnologyCSL BiotherapiesCSL LimitedFluvaxMarkets & MarketingVaccines

ABPI takes stand against medicine's money wasting middle-men

21-06-2012

The role of brokers in the medicine transactional process has been denounced by Stephen Whitehead, chief…

BiotechnologyEuropeMarkets & MarketingPharmaceutical

Intellectual property encourages collaboration, R&D in developing economies

21-06-2012

The USA-based Biotechnology Industry Organization (BIO) unveiled a report on the role of intellectual…

BiotechnologyGlobalPatentsPharmaceuticalResearch

XTL Biopharma to acquire Kitov Pharmaceuticals

21-06-2012

Israeli biopharma firm XTL Biopharmaceuticals (TASE:XTL) says it will acquire fellow Israel-based Kitov…

BiotechnologyKitov PharmaceuticalsMergers & AcquisitionsPharmaceuticalXTL Biopharmaceuticals

1930 to 1954 of 2375 results

Back to top